Brevan Howard Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$607K Buy
25,938
+1,386
+6% +$25.1K 0.01% 1186
2025
Q4
$348K Buy
24,552
+8,730
+55% +$165K ﹤0.01% 1296
2025
Q3
$392K Buy
+15,822
New +$353K ﹤0.01% 1415
2025
Q1
Sell
-6,916
Closed -$274K 1124
2024
Q4
$274K Sell
6,916
-3,971
-36% -$179K ﹤0.01% 808
2024
Q3
$690K Buy
10,887
+6,541
+151% +$472K ﹤0.01% 584
2024
Q2
$294K Buy
+4,346
New +$303K ﹤0.01% 785
2024
Q1
Sell
-2,898
Closed -$225K 967
2023
Q4
$225K Buy
+2,898
New +$215K ﹤0.01% 841

Other funds holding ACHC

Brevan Howard Capital Management's ACHC Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Acadia Healthcare (ACHC) stake by 5.6% in Q1 2026, buying an estimated $25.1K and bringing the position to 25,938 shares worth $607K. The position accounts for 0.01% of the portfolio, ranked #1186.

Brevan Howard Capital Management first reported a position in ACHC in Q4 2023 and has held it in 7 quarters since. The position peaked at $690K in Q3 2024. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Brevan Howard Capital Management held 25,938 shares of Acadia Healthcare worth $607K as of Q1 2026.
  • Brevan Howard Capital Management bought 1,386 Acadia Healthcare shares in Q1 2026, an estimated $25.1K.
  • Acadia Healthcare made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1186 holding.
  • Brevan Howard Capital Management first reported a position in Acadia Healthcare in Q4 2023 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Acadia Healthcare position peaked at $690K in Q3 2024.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.